The Virtual 2021 Ryan White HIV/AIDS Program CLINICAL CONFERENCE

Course Chairs

Laura W. Cheever, MD, ScM
HIV/AIDS Bureau, The Health Resources and Services Administration
Michael S. Saag, MD
University of Alabama at Birmingham
Allison L. Agwu, MD, ScM
The Johns Hopkins University

Faculty

Allison L. Agwu, MD, ScM
The Johns Hopkins University
Wendy Armstrong, MD
Wendy S. Armstrong, MD
Emory University
Atlanta, GA
Roger J. Bedimo, MD, MS
University of Texas Southwestern Medical Center
Dallas, TX
Connie L. Celum, MD, MPH
University of Washington
Seattle, WA
Laura W. Cheever, MD, ScM
HIV/AIDS Bureau, The Health Resources and Services Administration
Francine Cournos, MD
Francine Cournos, MD
Columbia University
New York, NY
Susan Cu-Uvin, MD
Susan Cu-Uvin, MD
Brown University
Providence, RI
Judith S. Currier, MD
University of California Los Angeles
Jodie A. Dionne, MD, MSPH
University of Alabama at Birmingham
Birmingham, AL
Monica Gandhi, MD, MPH
University of California San Francisco
San Francisco, CA
Rajesh T. Gandhi, MD
Harvard University
Boston, MA
Khalil G. Ghanem, MD, PhD
Khalil G. Ghanem, MD, PhD
The Johns Hopkins University
Baltimore, MD
Meredith Greene, MD
Meredith Greene, MD
Indiana University School of Medicine
Rachel Bender Ignacio, MD, MPH
University of Washington
Seattle, WA
Nadine Kaslow
Nadine J. Kaslow, PhD
Emory University
Atlanta, GA
Jennifer J. Kiser, PharmD, PhD
University of Colorado
Aurora, CO
Raphael J. Landovitz, MD, MSc
University of California Los Angeles
Los Angeles, CA
James Raper
James Raper, PhD, DSN, CRNP, JD
University of Alabama at Birmingham
Birmingham, AL
Michael S. Saag, MD
University of Alabama at Birmingham
Melanie Thompson, MD
Melanie A. Thompson, MD
Thacker & Thompson, MD
Atlanta, GA
Ronald D. Wilcox, MD
The Health Resources and Services Administration
Rockville, MD
Timothy J. Wilkin, MD, MPH
University of California San Diego

Special Sunday Panelists

Marcus Conant, MD
San Francisco AIDS Foundation
San Francisco, CA
Kathleen A. Clanon, MD
Alameda Care Connect
Oakland, CA
Alison Moed, RN
San Francisco General Hospital
San Francisco, CA
Michael Reyes, MD
University of California San Francisco
San Francisco, CA
Paul A. Volberding, MD
University of California San Francisco
San Francisco, CA

October 3 - 6, 2021

The virtual conference will be hosted through this activity page. You will need your IAS–USA login information to access all virtual content.

Due to the rapid rise of COVID-19 delta variant infections, we have come to the difficult decision that it is unsafe and impractical to have the in-person component of the 2021 RWHAP CLINICAL CONFERENCE. Our first and foremost concern is to ensure our attendees’ health and safety and decided the safest option is to only have the virtual component of the conference. The conference dates will remain the same and the updated agenda, including the updated conference hours, is available in this activity page.

For more information, click here.

For FAQs, click here.

Overview

virtual 2021 RWHAP CLINICAL CONFERENCE Description

The virtual Ryan White HIV/AIDS Program (RWHAP) CLINICAL CONFERENCE will will be held from Sunday, October 3 to Wednesday, October 6. The virtual RWHAP CLINICAL CONFERENCE will provide state-of-the-art updates on research, care, and treatment issues in the medical management of HIV infection for experienced HIV clinical decision makers.

The virtual RWHAP CLINICAL CONFERENCE is planned with and supported by the HIV/AIDS Bureau, Health Resources and Services Administration of the US Department of Health and Human Services (HRSA) and is sponsored and organized by the International Antiviral Society-USA (IAS-USA). This conference is coordinated through the RWHAP AIDS Education and Training Centers (AETC) clinician training network. A mix of lectures, case-based interactive presentations, and small-group workshop breakout sessions will be held during the 4 days of the virtual RWHAP CLINICAL CONFERENCE.

Who Should Attend

Attendance is limited to 600 HIV physicians, nurse practitioners, and physician assistants in Ryan White HIV/AIDS Program (RWHAP)-funded clinics and programs (specifically for in part A, B, C, and D). The virtual RWHAP CLINICAL CONFERENCE will offer an increased limit of virtual registrations for RNs and PharmDs who are the primary clinical care decision makers in their RWHAP-funded clinics or programs and is restricted to up to 7 attendees per size of the clinic. There is no registration fee to attend.

Learning Objectives

The educational objectives for the virtual 2021 RWHAP CLINICAL CONFERENCE are designed and developed based on the identified needs and knowledge gaps of the attendees.

On completion of the virtual 2021 RWHAP CLINICAL CONFERENCE, participants will be able to:

  • Describe the new aspects to the Ryan White HIV/AIDS Program
  • Identify situations in which the choice of antiretroviral regimen should consider particular clinical circumstances, such as comorbid conditions, coinfections, pregnancy, and issues in older patients
  • Describe the most current data on currently available and investigational new antiretroviral drugs, formulations, and strategies
  • Initiate and monitor HIV prevention intervention strategies, including the use of preexposure prophylaxis (PrEP), in individuals at risk for HIV infection
  • Describe the current epidemiology, clinical presentations, and management of the most common sexually transmitted infections (STIs) in adults with HIV infection and in special populations such as adolescents
  • Detect, manage, and prevent common comorbidities occurring in the aging population of persons with HIV infection, including how to manage and prevent polypharmacy
  • Describe the current understanding of COVID-19 in people with HIV
  • Identify ways to prevent HIV-related comorbidities in adolescents
  • Detect and address depression in patients with HIV, as well as practitioner and staff burnout
  • Describe the current best practices of perinatal HIV care and prevention
  • Describe barriers and strategies for engaging out-of-care patients with HIV
  • Describe the risk factors and screening recommendations for non-AIDS cancers in people with HIV
  • Describe challenges and opportunities for utilizing telemedicine for the prevention and treatment of HIV

Continuing Education Credits

CME Credits

The International Antiviral Society–USA (IAS–USA) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The IAS–USA designates this live activity for a maximum of 14.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

ABIM MOC Points

ABIM MOCSuccessful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 14.5 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

American Academy of Family Physicians Credits

The AAFP has reviewed virtual 2021 Ryan White HIV/AIDS Program CLINICAL CONFERENCE and deemed it acceptable for up to 13.5 Online Only, Live AAFP Prescribed credit. Term of Approval is from 10/03/2021 to 10/06/2021. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing Credits

Educational Review Systems is an approved approver of continuing nursing education by the Alabama State Nursing Association, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation.  Provider # 5-115.  This program is approved for 14.5 hours of continuing nursing education.

Educational Review Systems is also approved for nursing continuing education by the state of California, the state of Florida and the District of Columbia.

This program is approved for 14.5 hours of pharmacotherapy credit.

Pharmacy Credits

Accreditation Council for Pharmacy Education logoEducational Review Systems is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education.   Participants of the session who complete the evaluation and provide accurate NABP e-Profile information will have their credit for 14.5 contact hours (1.45 CEU) submitted to CPE Monitor as early as 14 days after the event and no later than 60 days after the event.  Please know that if accurate e-Profile information is not provided within 60 days of the event, credit cannot be claimed after that time.  The participant is accountable for verifying the accurate posting of CE credit to their CPE Monitor account within 60 days.
UAN  # 0761-9999-21-304-L02-P

Grant Support

This conference is funded by Health Resources and Services Administration (HRSA) of the US Department of Health and Human Services (HHS) under grant number U1OHA28686 (AIDS Education and Training Center National Coordinating Resource Center) awarded François-Xavier Bagnoud Center from the Rutgers University School of Nursing with a sub award to International Antiviral Society–USA (IAS–USA) to sponsor this CME activity.

Apply to Attend

Applications must be approved to attend the virtual 2021 RWHAP CLINICAL CONFERENCE. If you do not receive an application status email notification within 2 business days of submitting your application, please check your spam folder. Otherwise, please email registration@iasusa.org.